Alem Truneh

Alem Truneh, Ph.D. co-founded ImCheck Therapeutics in 2015 and is the Chief Technology Officer of the company.

Previously, Alem Truneh co-founded NKT Therapeutics, Inc. in 2011 and served as its Chief Scientific Officer and Executive Vice President of Research & Development. He is today a member of the Scientific Advisory Board of this company.

Mr. Truneh is a senior pharmaceutical executive with over 25 years of experience in biomedical R&D. Truneh spent 17 years at GlaxoSmithKline (GSK) where he helped advance several products, biologics, as well as small molecule drugs, from early discovery through advanced clinical trials, and post-market product differentiation and line extensions.

Truneh spent over 4 years as Vice President and Senior Vice President of R&D at Antigenics and TolerRx, respectively, where he oversaw programs in cancer, autoimmune and allergic disorders and infectious diseases.

Alem Truneh is the Chief Technology Officer at ImCheck Therapeutics, based in United States, North America. With a background in Biotechnology, Alem Truneh has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.